Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Culver

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
cis-2,6-Dibenzyl-cyclo-hexa-noneJohn P Culver, Sean Parkin, Peter A Crooks
Bioorganic & Medicinal Chemistry Letters|August 16, 2016
Synthesis and in vitro evaluation of water-soluble 1,4-diphenethylpiperazine analogs as novel inhibitors of the vesicular monoamine transporter-2Justin R Nickell, John P Culver, Venumadhav Janganati, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2016
1,4-Diphenalkylpiperidines: A new scaffold for the design of potent inhibitors of the vesicular monoamine transporter-2Justin R Nickell, John P Culver, Venumadhav Janganati, et al.
Current Topics in Medicinal Chemistry|November 6, 2010
Design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abusePeter A Crooks, Guangrong Zheng, Ashish P Vartak, et al.
Biochemical Pharmacology|April 5, 2024
Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in ratsCassie M Chandler, Justin R Nickell, A George Wilson, et al.
Medchemcomm|March 26, 2013
Exploring the effect of <i>N</i>-substitution in <i>nor</i>-lobelane on the interaction with VMAT2: discovery of a potential clinical candidate for treatment of methamphetamine abuseGuangrong Zheng, David B Horton, Narsimha Reddy Penthala, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 24, 2010
meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine releaseDavid B Horton, Kiran B Siripurapu, Seth D Norrholm, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
cis-2,6-Dibenzyl-cyclo-hexa-noneJohn P Culver, Sean Parkin, Peter A Crooks
Bioorganic & Medicinal Chemistry Letters|August 16, 2016
Synthesis and in vitro evaluation of water-soluble 1,4-diphenethylpiperazine analogs as novel inhibitors of the vesicular monoamine transporter-2Justin R Nickell, John P Culver, Venumadhav Janganati, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2016
1,4-Diphenalkylpiperidines: A new scaffold for the design of potent inhibitors of the vesicular monoamine transporter-2Justin R Nickell, John P Culver, Venumadhav Janganati, et al.
Current Topics in Medicinal Chemistry|November 6, 2010
Design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abusePeter A Crooks, Guangrong Zheng, Ashish P Vartak, et al.
Biochemical Pharmacology|April 5, 2024
Vesicular monoamine transporter-2 inhibitor JPC-141 prevents methamphetamine-induced dopamine toxicity and blocks methamphetamine self-administration in ratsCassie M Chandler, Justin R Nickell, A George Wilson, et al.
Medchemcomm|March 26, 2013
Exploring the effect of <i>N</i>-substitution in <i>nor</i>-lobelane on the interaction with VMAT2: discovery of a potential clinical candidate for treatment of methamphetamine abuseGuangrong Zheng, David B Horton, Narsimha Reddy Penthala, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 24, 2010
meso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine releaseDavid B Horton, Kiran B Siripurapu, Seth D Norrholm, et al.
Pageof 1